To the Editor—I enjoyed the article by Cho et al1 titled, “Early postoperative outcome of bipolar transurethral enucleation and resection of the prostate,” published in the December 2015 issue of Hong Kong Medical Journal. I noted with interest that the authors reported no urethral stricture, meatal stenosis, or bladder neck contracture at 3 months despite the larger prostates and more difficul...

Background: Transurethral resection of the prostate (TURP) is gold-standard treatment for benign prostatic hyperplasia (BPH). However, laser surgery techniques (e.g., photoselective vaporization (PVP), holmium laser, thulium enucleation (HoLEP or ThuLEP)), and minimally invasive options UroLift) are increasingly replacing TURP. This study seeks to report annual incidence, management trends, cos...

PURPOSE Approximately 20% to 30% of patients with benign prostatic hyperplasia (BPH) require medication or supplementary treatment for their continuous irritative bladder symptoms after transurethral resection of the prostate (TURP). The purpose of this study was to identify any factors related to continuous bladder irritation in patients after TURP. MATERIALS AND METHODS Of all patients who ...

Subcutaneous emphysema is a very rare and good-natured complication after transurethral resection of prostate (TURP). It has been reported as colon perforation, diverticulitis, and bladder perforation associated complication previously. We report the first case of a wide subcutaneous emphysema due to microperforations of prostatic capsule, without a bladder perforation after TURP. Any sign of c...

Background: Transurethral resection of the prostate (TURP) remains the Gold Standard surgical treatment of Benign Prostate Enlargement. Hemorrhage during and after TURP can lead to significant morbidity and occasionally prove fatal. Objective: Our study aimed to evaluate the trend of blood loss in transurethral resection of the prostate for patients who presented with benign prostate enlargemen...

BACKGROUND Benign prostatic hyperplasia (BPH) is a prevalent entity in elderly men and transurethral resection of the prostate (TURP) still represents the gold standard of surgical treatment despite its considerable perioperative morbidity. Recently, prostatic artery embolization (PAE) was described as a novel effective and less invasive treatment alternative. Despite promising first results, P...

Introduction : Transurethral enucleation and resection of the prostate (TUERP) may offer a better treatment for benign prostatic enlargement. We compared the perioperative parameters and outcome following bipolar plasmakinetic transurethral resection of the prostate (TURP) and TUERP. Methods : Data from two independent institutions were reviewed retrospectively. 50 and 45 consecutive patients w...

Background: Monopolar transurethral resection of prostate has long been a standard method of managements of benign prostatic hyperplasia. The safe and superior efficacy of transurethral resection of prostate (TURP) always argues strongly for maintaining it as the primary mode of therapy for patients with benign prostatic hyperplasia (BPH). There is a trend toward early catheter removal after tr...

PURPOSE Prostate-specific antigen (PSA) is the most important marker in the diagnosis and follow-up of patients with prostate cancer. The primary objective of this study was to evaluate the effect of various urologic procedures in prostatic area on serum free and total PSA levels. SUBJECTS AND METHODS A series of 62 patients (8 after digital rectal examination [DRE], 12 after transrectal ultr...

A systematic review of randomized controlled trials and cohort studies was conducted to evaluate data for the effects of minimally invasive procedures for treatment of symptomatic benign prostatic hyperplasia (BPH) on male sexual function. The studies searched were trials that enrolled men with symptomatic BPH who were treated with laser surgeries, transurethral microwave therapy (TUMT), transu...